Status:
COMPLETED
Effect of Motivational Therapy on Schizophrenia With Cannabis Misuse
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Schizophrenia
Cannabis Dependence, Continuous
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Schizophrenia is a severe mental illness with a lifetime morbidity risk close to 1 %, involving both genetic and environmental risk factors. Prospective studies have shown that heavy use of cannabis i...
Detailed Description
Schizophrenia is a severe mental illness with a lifetime morbidity risk close to 1 %, involving both genetic and environmental risk factors. Prospective studies have shown that heavy use of cannabis i...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Schizophrenia or schizo-affective disorder according to DSM-IV criteria
- Meeting DSM-IV criteria for actual cannabis abuse or dependance
- in current and regular contact with mental health service
- with an age at interview of 18 years or more
- No evidence of organic brain disease or clinically significant concurrent medical illness or learning disability
- Written informed consent was obtained from all subjects (patients and parents).
- EXCLUSION CRITERIA:
- Not membership to a regime of social security or to a CMU
Exclusion
Key Trial Info
Start Date :
November 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2013
Estimated Enrollment :
97 Patients enrolled
Trial Details
Trial ID
NCT00798109
Start Date
November 1 2008
End Date
April 1 2013
Last Update
June 16 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de psychiatrie (Pr Adès)
Colombes, France, 92700